IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $458,000 | -61.8% | 352,300 | 0.0% | 0.42% | -41.6% |
| Q3 2018 | $1,198,000 | -26.1% | 352,300 | 0.0% | 0.71% | -23.1% |
| Q2 2018 | $1,621,000 | +41.6% | 352,300 | 0.0% | 0.93% | +30.1% |
| Q1 2018 | $1,145,000 | -16.7% | 352,300 | 0.0% | 0.71% | -28.5% |
| Q4 2017 | $1,374,000 | -62.3% | 352,300 | 0.0% | 1.00% | -60.5% |
| Q3 2017 | $3,646,000 | +7.2% | 352,300 | 0.0% | 2.52% | -6.7% |
| Q2 2017 | $3,400,000 | +43.0% | 352,300 | 0.0% | 2.71% | +52.7% |
| Q1 2017 | $2,378,000 | +121.2% | 352,300 | +78.6% | 1.77% | +97.1% |
| Q4 2016 | $1,075,000 | -28.0% | 197,300 | 0.0% | 0.90% | -37.2% |
| Q3 2016 | $1,494,000 | -7.2% | 197,300 | 0.0% | 1.43% | -15.1% |
| Q2 2016 | $1,610,000 | – | 197,300 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |